Replimune

reducing people on team
Biotech

Shedding 60% of workforce, Replimune vows to continue operations

Replimune is saying goodbye to a further 161 staffers across two Massachusetts sites.
Darren Incorvaia Apr 21, 2026 2:15am
dart board miss failure

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm
gold arrow pointing upward forward

Replimune's stock spikes 100% on FDA acceptance of resubmission

Oct 20, 2025 5:33pm
Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects another ultrarare disease prospect

Sep 8, 2025 10:59am
FDA

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm
dominoes fall series fail

Krystal discontinues melanoma study after FDA's Replimune rebuff

Aug 21, 2025 10:50am